Design, synthesis, in vitro, in vivo and in silico pharmacological characterization of antidiabetic N-Boc-l-tyrosine-based compounds
Miguel Herrera-Rueda(Universidad Autónoma del Estado de Morelos), Gabriel Navarrete‐Vázquez(Universidad Autónoma del Estado de Morelos), Julio Cesar Almanza-Pérez(Universidad Autónoma Metropolitana), Horacio Pérez‐Sánchez(Universidad Católica de Murcia), Paolo Paoli(University of Florence), Samuel Estrada‐Soto(Universidad Autónoma del Estado de Morelos), Abraham Gutiérrez-Hernández(Universidad Autónoma del Estado de Morelos), Fabiola Chávez-Silva(Universidad Autónoma del Estado de Morelos), Hugo Tlahuext(Universidad Autónoma del Estado de Morelos), Abraham Giacoman‐Martínez(Universidad Autónoma Metropolitana), Elix Alberto Domínguez-Mendoza(Universidad Autónoma del Estado de Morelos)
Cited by 11
Related Papers
MCC950 closes the active conformation of NLRP3 to an inactive state
|Nature Chemical Biology|2019|446
Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks
|Drug Discovery Today|2018|224
A Comprehensive Docking and MM/GBSA Rescoring Study of Ligand Recognition upon Binding Antithrombin
|Current Topics in Medicinal Chemistry|2017|193
High-Throughput parallel blind Virtual Screening using BINDSURF
|BMC Bioinformatics|2012|190
Managing, Analysing, and Integrating Big Data in Medical Bioinformatics: Open Problems and Future Perspectives
|BioMed Research International|2014|175